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Abstract
Fear is one of the most potent emotional experiences and is an adaptive component of response to potentially threatening
stimuli. On the other hand, too much or inappropriate fear accounts for many common psychiatric problems. Cumulative
evidence suggests that the amygdala plays a central role in the acquisition, storage and expression of fear memory. Here,
we developed an inducible striatal neuron ablation system in transgenic mice. The ablation of striatal neurons in the adult
brain hardly affected the auditory fear learning under the standard condition in agreement with previous studies. When
conditioned with a low-intensity unconditioned stimulus, however, the formation of long-term fear memory but not short-
tem memory was impaired in striatal neuron-ablated mice. Consistently, the ablation of striatal neurons 24 h after
conditioning with the low-intensity unconditioned stimulus, when the long-term fear memory was formed, diminished the
retention of the long-term memory. Our results reveal a novel form of the auditory fear memory depending on striatal
neurons at the low-intensity unconditioned stimulus.
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Introduction
Fear is one of the most potent emotional experiences of our
lifetime and is an adaptive component of response to potentially
threatening stimuli, serving a function that is critical to the survival
of higher vertebrates [1,2]. Too much or inappropriate fear,
however, accounts for many common psychiatric problems [3–5].
A fearful experience can establish an emotional memory that
results in permanent behavioral changes and emotional memories
have been observed in many animal groups [6]. The brain
mechanisms underlying fear are similar in different species and the
fear system will respond similarly in a person or a rodent, using a
limited set of defense response strategies [7]. The memory of
learned fear can be assessed quantitatively using a Pavlovian fear-
conditioning paradigm [1,2]. During fear conditioning, an initially
neutral conditioned stimulus (CS, e.g. an auditory tone) acquires
biological significance by becoming associated with an aversive
unconditioned stimulus (US, e.g. a footshock). After learning this
association, an animal responds to the previously neutral CS with
a set of defensive behavioral responses, such as freezing.
Anatomical tracing and lesion studies demonstrated the impor-
tance of the amygdala for fear conditioning [8–10]. Subsequent
physiological experiments showed that learning produces pro-
longed synaptic modification in both of the inputs to the
amygdala: the thalamo-amygdala pathway [11,12] and the
cortico-amygdala pathway [13]. Evidence from many studies
suggests that the amygdala—in particular, the lateral/basolateral
nuclei—plays an essential role in the acquisition, storage and
expression of fear memory [1,7,14–18].
Here, we developed an inducible striatal neuron ablation system
in transgenic mice and examined the effect of striatal neuron
ablation on auditory fear conditioning with different intensities of
US. Under the standard condition, the ablation of striatal neurons
in the adult brain hardly affected the auditory fear conditioning in
agreement with previous studies [18–22]. We found, however, that
under a weak condition, the formation of long-term auditory fear
memory but not short-term memory was impaired by the ablation
of striatal neurons. Our results suggest the presence of two forms of
auditory fear memories distinguished by the US intensity and by
the requirement of striatal neurons. Our finding that striatal
neuron ablation diminished the auditory fear conditioning only
when the US was weak is intriguing since the striatum is supposed
to play a role in incorporating the positive or negative value of
information into the determination of behavioral responses.
Results
Generation of striatum-specific Cre mouse lines
The G-protein c7 subunit mRNA is expressed predominantly in
medium spiny neurons of the caudate-putamen (CP) and nucleus
PLoS ONE | www.plosone.org 1 January 2009 | Volume 4 | Issue 1 | e4157accumbens (NAc) and neurons of the olfactory tubercle [23]. To
develop a striatal neuron-specific gene manipulation system, we
produced Gc7-Cre and Gc7-mCrePR mouse lines by inserting the
gene encoding Cre recombinase or Cre recombinase-progesterone
receptor fusing protein (CrePR) into the translational initiation site
of the G-protein c7 subunit gene (Gng7) through homologous
recombination in embryonic stem cells derived from the C57BL/6
strain [24] (Fig. 1A). We then crossed the Gc7-Cre and Gc7-
mCrePR mice with the CAG-CAT-Z11 reporter mouse [25].
Brain slices prepared from Gc7-Cre6CAG-CAT-Z11 mice were
stained for b-galactosidase activity to monitor the Cre recombi-
nase activity. Strong b-galactosidase staining was found predom-
inantly in the CP, NAc and olfactory tubercle. Faint signals were
detected in the layer 5 of the neocortex and subiculum (Fig. 1B).
On the other hand, no b-galactosidase staining was detectable in
brain slices from Gc7-mCrePR6CAG-CAT-Z11 mice upon
induction of Cre recombinase activity by RU-486 administration.
Inducible ablation of striatal neurons
We then crossed the Gc7-mCrePR mouse with a knock-in mouse
(Eno2-STOP-DTA) in which the Cre-inducible diphtheria toxin A
gene (DTA) was introduced into the neuron-specific enolase gene
(Eno2)l o c u s[ 2 6 ] .I nGng7
+/mCrePR mice, one allele retains the intact
Gng7 gene, and the other is inactivated by insertion of the CrePR
gene. We injected 1 mg per g body weight of RU-486 into the
peritoneum of Gc7-mCrePR6Eno2-STOP-DTA mice at postnatal
day 42 (P42) to induce the recombinase activity of CrePR [24,25,27]
(Fig. 2A). Mock-injected mice served as controls. Ten days after RU-
486 injection, TUNEL staining showed strong signals throughout
the striatum, including the CP, NAc and olfactory tubercle (Fig. 2B).
On the other hand, no TUNEL-signals were detectable in the
striatumofthemock-injectedmice.BothRU-486-and mock-treated
mice showed faint TUNEL-signals in the olfactory bulb probably
due totheturnoverof adult-generated olfactorygranulecells [28].In
addition, Gc7-mCrePR mice exhibited no detectable TUNEL
signals in the striatum upon RU-486 injection (data not shown).
These results suggest that RU-486 treatment successfully induced
recombination by CrePR, leading to cell ablation in the adult brain
in the striatum-specific manner. Gc7-CrePR-mediated recombina-
tion appeared to be critically dependent on target mice since b-
galactosidase staining was hardly detectable in Gc7-mCrePR6
CAG-CAT-Z11 mice upon induction.
Thirteen days after RU-486 treatment, TUNEL signals in the
striatum became undetectable in Gc7-mCrePR6Eno2-STOP-
DTA mice. We then quantitatively examined the ablation of
striatal neurons by immunohistochemical staining for NeuN, a
marker protein for neurons. The density of NeuN-positive neurons
in the CP drastically decreased by 13 days after RU-486 injection
(F6,54=99.5, P,0.001, one-way ANOVA) and remained at a very
low level thereafter (Fig. 3A–C). The number of NeuN-positive
cells in the NAc core and shell also decreased with a similar time
course (Fig. 3B,D). However, NeuN immunostaining signals in
other brain regions including the amygdala were comparable
between mock- and RU-486-treated mice (Fig. 3B,E).
Medium-spiny projection neurons, the main output neurons,
account for up to 90% of neurons in the striatum [29,30]. There
were no detectable immunoreactivities for calbindin, a marker for
medium-sized spiny neurons [31], in the mutant striatum (Fig. 4A).
Medium-spiny projection neurons in the striatum can be largely
subdivided into two groups: some that project to directly to the
substantia nigra pars reticulata (SNr) (the direct pathway) express
substance P; others that project to the same nucleus via the globus
pallidus (GP) (the indirect pathway) express enkephalin [29].
These two neuropeptides are anterogradely transported to the
axon terminals in the afferent regions [32]. There were no
detectable immunoreactivities for substance P and enkephalin in
Figure 1. Generation of Gc7-Cre and Gc7-mCrePR mice. A, Schema of the exon 4 region containing the translational initiation site of the Gng7
gene, targeting vector, and targeted allele. The targeting vector carries the cre or mCrePR gene and the neo gene flanked by two frt sequences. A,
ApaI; EV, EcoRV; K, KpnI; S, SpeI. B, LacZ expression following Cre recombination. X-gal-staining of sagittal and coronal sections from Gng7
+/cre; +/CAG-
CAT-Z mice at postnatal day 14. Sections were counterstained with nuclear fast red. Abbreviations: Ce, cerebellum; Cx, cortex; Hi, hippocampus; Po,
pons; St, striatum; Th, thalamus. Scale bars, 1 mm.
doi:10.1371/journal.pone.0004157.g001
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suggesting that any striatal output scarcely remains in the basal
ganglia of the mutant mice. Along with the NeuN-immunohisto-
chemistry, our results suggest that induction of CrePR-mediated
DTA expression by RU-486 injection successfully ablated almost
completely the medium spiny neurons that comprise approxi-
mately 90% of the NeuN-positive striatal neurons within 13 days.
In subsequent analyses, we used Gc7-mCrePR6Eno2-STOP-
DTA mice from 13 to 22 days after RU-486 administration as
striatal neuron-ablated mutant mice and corresponding mock-
injected littermates served as controls.
Motor activity
The striatum is intimately involved in motor control. The
striatal neuron-ablated mutant mice showed no ataxic gait or
tremor and could walk along a straight line as control did (control,
n=4; mutant, n=4) (Fig. 5A). There was no significant difference
in the performance in the stationary thin rod test [33] between
mutant and control mice (F1,15=1.38, P=0.26, repeated measures
ANOVA) (Fig. 5C). Thus, the ablation of striatal neurons
appeared to exert little effect on motor coordination under
standard conditions at least for a week after loss of ,90% striatal
neurons. In the accelerating rotarod test [34], both mutant and
Figure 2. Inducible ablation of striatal neurons. A, Schema for striatal neuron ablation induced by RU-486 administration. B, TUNEL staining
(green) counterstained with DAPI (blue) in brain sections of control (left) and mutant (right) mice 10 days after mock and RU-486 administration,
respectively. Scale bars, 1 mm. Abbreviations: Ce, cerebellum; Cx, cortex; Hi, hippocampus; Po, pons; St, striatum; Th, thalamus.
doi:10.1371/journal.pone.0004157.g002
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(F1,14=3.57, P=0.08, one-way ANOVA) (Fig. 5D). Despite that
approximately 90% of striatal neurons were ablated, the motor
performance of the mutant mice appeared to be comparable to
that of control mice in stationary thin rod and rotating rod tests. In
subsequent sessions of the accelerating rotarod test, however, there
was a significant difference in the retention time between two
groups (F1,14=37.2, P,0.001, repeated measures ANOVA).
Control mice showed a steady and rapid improvement in their
performance over the training. In contrast, mutant mice failed to
exhibit any improvements over trials, suggesting that the striatal
neurons are indispensable for motor learning. Our results are
consistent with the observation that striatum-specific NMDA
receptor mutant mice showed impaired motor learning in an
accelerating rotarod test [35]. In the open field test, the locomotor
activity of mutant mice tended to be higher than that of control
mice (F1,15=4.6, P=0.05) (Fig. 5E).
The degeneration of striatal neurons is associated with
Huntington’s disease [36,37] and dystonia [38,39]. Mutant mice,
however, showed no abnormal clasping behavior induced by a tail
suspension in a dystonic fashion (n=6) (Fig. 5B); the clasping
behavior was observed in the mutant mice 6 weeks after RU-486
injection. In addition, there were no easily recognizable movement
disorders in mutant mice at least for a week after the drug-induced
ablation of striatal neurons had been completed.
Impairment of auditory fear conditioning with a low-
intensity footshock
Mutant mice were subjected to auditory fear conditioning to
examinethepossibleinvolvementofstriatalneuronsintheformation
of the emotional memory. Fourteen days after RU-486 treatment,
mutant mice were trained for auditory fear conditioning (Fig. 6A).
Mice were given a single pairing of tone (CS) and footshock (US;
0.5 mA) on the conditioning day (Fig. 6B). Twenty-four hours after
the conditioning, the mice were placed in a novel chamber. Six min
after placement, the tone was delivered for 3 min. Mice exhibited a
range of conditioned fear responses including freezing. Levels of
freezing during the pre-tone period were comparable between
mutant and control mice (F1,15=2.28,P=0.15). Freezing responses
to the tone were also similar between mutant and control mice
(control, 31.665.1%; mutant, 28.065.1%; F1,15=0.27, P=0.61)
(Fig. 6B). Thus, mutant mice successfully acquired fear memory
under the standard condition despite of almost complete ablation of
striatal medium spiny neurons.
We further investigated the ability of mutant mice to acquire
fear memory under a less intensive condition. Mice were trained
with a single paring of the tone and a low-intensity footshock at
0.3 mA, and tested for the freezing response 24 h after training.
Negligible levels of freezing were observed during the pre-tone
period in control and mutant mice as well as RU-486-treated Gc7-
mCrePR mice (RU-486 control). However, there were significant
differences in the freezing responses across the CS presentation
among 3 groups of mice (control, 29.764.9%; RU-486 control,
31.564.9%; mutant, 13.662.7%; F2,23=6.57, P=0.006) (Fig. 6C).
The freezing levels of mutant mice were much lower than those of
control mice (P,0.05, mutant vs. control; P,0.01, mutant vs.
RU-486 control; Post-hoc analysis). Comparable levels of freezing
between control and RU-486-control mice indicated that
treatment of RU-486 itself exerted little effect on the fear
conditioning. There were no significant differences among control,
RU-486 control, and mutant mice in pain thresholds for flinch and
jump reactions (flinch, F2,16=0.094, P=0.91, one-way ANOVA;
jump, F2,16=0.021, P=0.98) (Fig. 6D). The post-shock activity
bursts [40] of mutant and control mice were also similar (at
Figure 3. NeuN-immunohistochemstry. A, Immunohistochemical
analysisforneuronal marker NeuNin control (left)andmutant(right) mice
13 days after mock and RU-486 administration, respectively. Scale bar,
1m m .B, Higher magnification ofNeuN-immunohistochemistry invarious
brain regions. Scale bars, 0.1 mm. C, NeuN immunoreactive (NeuN
+)-cell
density in the CP after drug administration. n=8–9 each. D, Densities of
NeuN-positive cells in the NAc core (NAcC, open circles) and the NAc shell
(NAcS, filled circles) after RU-486 treatment of Gng7
+/mCrePR; +/Eno2-STOP-
DTA mice (n=8–9 each). E, Densities of NeuN-positive cells in the lateral
amygdala (LA)of control and mutantmice 22days after mock andRU-486
treatment, respectively (n=15 each, F1,28=0.23, P=0.64, one-way
ANOVA). Abbreviations: Au, auditory cortex; CA1, hippocampal CA1
region;CP,caudate putamen; Cx,cortex; GP, globus pallidus; MGN,medial
geniculate nucleus of thalamus; NAc, nucleus accumbens; OT, olfactory
tubercle; PAG, periaqueductal gray; Sp, septum.
doi:10.1371/journal.pone.0004157.g003
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These results suggest that striatal neurons are indispensable for
efficient auditory fear conditioning with the low-intensity US.
Impairment of long-term fear memory
To further examine the role of striatal neurons in fear
conditioning, we trained mice under the weak condition (a single
paring of tone and footshock at 0.3 mA), tested for short-term
memory (STM) 1 or 3 h after training and then retested for long-
term memory (LTM) 24 h after training [41] (Fig. 7A). The freezing
responses of mutant mice were comparable to those of control mice
1 h after conditioning (control, 19.763.0%; mutant, 34.567.2%;
F1,11=3.20, P=0.10, repeated measures ANOVA) (Fig. 7B left
panel) as well as3 h after conditioning (control,20.663.6%;mutant,
24.267.1%; F1,8=0.51, P=0.50) (Fig. 7C left panel). Twenty-four
hours after training, however, mutant mice showed significantly
smaller freezing responses than control mice (Fig. 7B right panel,
control, 28.064.6%; mutant, 3.461.8%; F1,11=8.06, P=0.02:
Fig. 7C right panel, control, 17.764.0%; mutant, 2.961.2%;
F1,8=46.7,P,0.001). These results suggest that the striatal neurons
are involved selectively in the acquisition of LTM under the weak
conditioning, but not in that of STM. The intact STM formation in
mutant mice is consistent with no detectable alterations in the
sensitivity to the electric footshock as above.
Impairment of fear memory retention
We further examined whether the ablation of striatal neurons
affects the retention of previously acquired fear memory (Fig. 7D).
Mice were first trained with a single paring of tone and footshock
at 0.3 mA and placed back in the home cage. Twenty-four hours
after conditioning when LTM was formed, the animals were
treated with RU-486 for induction of striatal neuron ablation.
When tested 14 days after the drug treatment, RU-486-injected
mice showed significantly smaller freezing responses during tone
presentation than mock-injected mice (mock-injected mice,
37.663.9%; RU-486-injected mice, 11.562.6%; F1,13=41.9,
P,0.001) (Fig. 7E). On the other hand, the ability of RU-486-
injected mice to retain the acquired fear memory under the
standard condition (0.5 mA) was comparable to that of mock-
injected mice (mock-injected mice, 50.166.8%; RU-486-injected
mice, 40.868.0%; F1,11=0.32, P=0.58) (Fig. 7F), consistent with
the observation that pre-conditioning ablation of striatal neurons
hardly affected the auditory fear conditioning (Fig. 6B). These
results suggest that the striatal neurons are required for the
retention of fear memory previously acquired by the conditioning
with the low-intensity US.
Discussion
Here, we show that striatal neurons can be selectively ablated
upon induction in mice carrying Gng7-promoter-driven CrePR and
Cre-dependent DTA genes. Despite that approximately 90% of
striatal neurons were ablated, the motor performance of the
mutant mice appeared to be comparable to that of control mice in
stationary thin rod and rotating rod tests. However, the
improvement of the mutant mice in the performance over trials
was impaired in the accelerating rotarod test, suggesting the
requirement of striatal neurons for motor learning. In addition, the
mutant mice showed no abnormal behavior in the tail suspension
test and there were no easily recognizable movement disorders in
the mutant mice at least for a week after the drug-induced ablation
of striatal neurons had been completed. Interestingly, however, the
clasping behavior was observed 6 weeks after RU-486 injection.
The motor phenotypes of mutant mice appeared later might be
caused by secondary changes of the brain. It is known that
dystonic symptoms occur a long time after brain injury, suggesting
secondary changes [42,43].
One to several pairings of tones with footshocks at 0.5–2 mA
are generally used for fear conditioning in rodents [18–22]. The
Figure 4. Ablation of medium-spiny projection neurons in the striatum of mutant mice. A, Immunoreactivity for calbindin in the dorsal
striatum of control (upper) and mutant (lower) mice. B, Immunoreactivity for tyrosine hydroxylase and substance P in substantia nigra of control and
mutant mice. C, Immunoreactivity for GAD and enkephalin in GP of control and mutant mice. Abbreviations: CP, caudate putamen; GP, globus
pallidus; SNc, substantia nigra pars compacta; SNr, substantia nigra pars reticulata; VTA, ventral tegmental area. Scale bars, 1 mm.
doi:10.1371/journal.pone.0004157.g004
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conditioning with a single pairing of tone with the footshock at
0.5 mA. Our results are consistent with previous ones that
electrolytic or excitotoxic lesion of the striatum exerted little effect
on the auditory fear conditioning [19–21]. On the other hand, a
slight impairment of fear conditioning with 5 tone-footshock (0.5–
1 mA) pairings was reported for dorsal striatum- or NAc shell-
lesioned rats [44,45]. It will be difficult to ascertain whether the
discrepant behavioral effects of classical lesion studies were caused
by ablation of striatal neurons or other impairments. Our genetic
ablation system specific for striatal neurons provides evidence
supporting the view that the amygdala but not the striatum is
essential for the auditory fear conditioning under the standard
condition.
In the present investigation, we found that when the tone was
paired with the low-intensity footshock at 0.3 mA, the freezing
responses 24 h after conditioning were significantly reduced in the
striatal neuron-ablated mice. The impairment of tone-dependent
fear conditioning with the low-intensity US itself does not reveal a
specific role of these striatal neurons in either the learning or the
performance of conditioned fear. However, the observation that
the freezing responses of the mutant mice measured 1 h or 3 h
after conditioning with the low-intensity US were comparable with
those of control mice excluded the possibility that the striatal
neuron ablation simply disrupted the animal’s ability to make the
freezing responses. Furthermore, the mutant mice showed the
ability to acquire, retain and express the cued fear memory at least
for 3 h after conditioning with the low-intensity US. It is to be
noted with this respect that the induction of cell ablation was
selective for striatal neurons, leaving the amygdala intact, which
plays an essential role in the acquisition, storage and expression of
fear memory [2,18,20]. Thus, the striatal neuron ablation
appeared to impair the formation and/or retention of long-term
fear memory rather than performance or acquisition and
expression of fear memory. Consistently with this possibility, the
ablation of striatal neurons after long-term fear memory
formation, that is, 24 h after conditioning with the low-intensity
US, diminished the retention of the LTM.
These results obtained by the use of an inducible striatal
neuron-ablation system suggest the presence of at least two forms
of the auditory fear memories distinguished by the US intensity
and by the requirement of striatal neurons. Under the standard
condition, auditory fear memory formation is hardly affected by
the striatal neuron ablation, in agreement with previous studies
showing that the amygdala but not the striatum plays a central role
in the auditory fear conditioning [2,18–21]. When auditory fear
conditioning was carried out with the low-intensity US, the
formation of LTM but not STM became sensitive to striatal
Figure 5. Performance of mutant mice in motor tests. A, Foot print of control (left) and mutant (right) mice. Scale bar, 2 cm. B, Tail suspension
test of control (left) and mutant (right) mice. C, Performance of control (open circles, n=9) and mutant (filled circles, n=8) mice in the stationary thin
rod test. D, Performance of control (open circles) and mutant (filled circles) mice in the accelerating rotarod (n=8 each). E, Locomotor activity of
control (open circles, n=10) and mutant (filled circles, n=7) mice in the openfield test.
doi:10.1371/journal.pone.0004157.g005
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auditory fear memory depending on striatal neurons at the low-
intensity US. When the US becomes weaker, it will be less
threatening and more difficult to judge whether it is dangerous
enough to be memorized for animals. Our finding that striatal
neuron ablation diminished the auditory fear conditioning only
when a footshock was weak is of interest in view that the striatum is
supposed to play a role in incorporating the positive or negative
value of information into the determination of behavioral
responses [46–48]. It is possible, though not proven, that striatal
neurons may be activated by the weak US and directly or
indirectly involved in the consolidation or retrieval of the long-
term fear memory. While the contextual fear conditioning requires
the hippocampus and amygdala, our results suggest further
integration of brain systems for the emotional memory by showing
the involvement of the striatum in the auditory fear conditioning at
the weak US. Fear is an adaptive component of response to
potentially threatening stimuli, but too much or inappropriate fear
accounts for many common psychiatric problems, such as anxiety
disorders [3–5]. Advances in basic and clinical neuroscience
studies of fear are important for the development of strategies to
treat and cure anxiety disorders [49,50]. Thus, the finding of a
novel form of the auditory fear memory might have therapeutic
implications.
Materials and Methods
Generation of striatum-specific Cre mice
A full-length cDNA (210 bp) encoding the mouse G-protein c7
subunit was amplified with primers 59-GATGTCAGGTACTAA-
CAACGTCGCCC-39 and 59-CTAGAGAATTATGCAAGGC-
TTTTTGTCTTT-39 from a brain cDNA library from ICR mice.
Using the cDNA fragment as a probe, we isolated a BAC clone
containing the exon 4 and 5 of the Gng7 by screening a genomic
DNA library of C57BL/6 mouse (Genome systems, St. Louis,
MO). The 8.9 kb-SpeI-KpnI fragment from the BAC clone was
inserted into the SpeI-KpnI sites of pBluescript II SK(+) (Stratagene,
La Jolla, CA) to yield pGng7MET. The 523 bp EcoRI-AgeI
fragment generated by 2-step-PCR using pGng7MET and pNCre
[25] as templates and the 989 bp AgeI-EcoRI fragment from
pNCre were cloned into the EcoRI site of pBluescript II SK(+)t o
yield pGng7Cre. The 1.4 kb EcoRI-SacI fragment from
pGK1NeopA [27] was blunted and inserted into the EcoRV site
of pGng7Cre to yield pCreNeo. Synthetic oligonucleotides (59-
AGCTTTCAGGTACTAACAACGTCGCCCAGGCCCGGA-
AGCTGGTGGAGCAGC-39 and 59-GCAGCTGCTCCACCA-
GCTTCCGGGCCTGGGCGACGTTCTTAGTACCTGAA-39)
and the 7.5 kb FspI-KpnI fragment from pGngMET were ligated
with the HindIII (blunted)- and KpnI-digested pBluescript II
SK(+) to yield pFSKP. The 7.5 kb EcoRV-KpnI fragment from
pFSKP was ligated with the HindIII (blunted)- and KpnI-digested
pCreNeo to yield pBTV. KpnI-digested pMC1DTApA was
blunted and ligated, and the 4.3 kb NotI-HindIII fragment from
the resulting plasmid was ligated with synthetic oligonucleotides,
59-GGCCGCGGTACCCGGGTCGACTTA-39 and 59-AGCT-
TAAGTCGACCCGGGTACCGC-39, to yield pMC1DTApA2.
The 11.1 kb NotI-KpnI fragment of pBTV was inserted into the
NotI-KpnI sites of pMC1DTpA2 to yield targeting vector
pGng7CreTV. The Cre coding sequence of the CrePR gene
[25,27] was replaced by that of mammalian Cre with the
optimal codon usage in mammals by 2-step PCR using
pNCrePR [25] and pCXN-Cre [51]. The 1.9-kb fragment
encoding mammalian CrePR (mCrePR) was cloned into the
XbaI site of pEF-BOS [52] to yield pmNCrePR. The cre gene in
pGngCreTV was replaced by the mCrePR gene to yield targeting
vector pGngmCrePRTV.
The targeting vectors were linearized by KpnI and electropo-
rated into ES cells derived from the C57BL/6 strain [24,27].
Recombinant clones were identified by Southern blot analysis of
genomic DNA using 0.25 kb AgeI-SpeI fragment from the BAC
clone, 0.6 kb-PstI-PstI fragment from pPGK1-NeopA and 0.3 kb
NdeI-SacI fragment from the BAC clone as 59 outer, neo, and 39
outer probes, respectively. Chimeric mice production was carried
out essentially as described [24,27]. The Gng7
Cre allele was
identified by PCR using primers CreP1 and CreP2 [25]. The
Figure 6. Impaired freezing responses of mutant mice after
auditory fear conditioning with a low-intensity footshock. A,
Experimental design. Mice were injected with RU-486 or vehicle.
Fourteen days after treatment, the animals were subjected to auditory
fear conditioning. B, Freezing responses of control (open circles, n=9)
and mutant (filled circles, n=8) mice on the conditioning (left) and test
(right) days. Auditory fear conditioning was carried out with the
standard intensity of footshock (0.5 mA, an arrow). Solid lines represent
tone. C, Freezing responses of control (open circles, n=8) and mutant
(filled circles, n=11) mice and RU-486-treated Gc7-mCrePR mice (RU-
486 control) (shaded triangles, n=7) on the conditioning (left) and test
(right) days. Auditory fear conditioning was carried out with a low
intensity of footshock (0.3 mA, an arrow). Solid lines represent tone. D,
Current thresholds of control (open bar), RU-486-control (shaded bar)
and mutant (filled bar) mice for flinch and jump reactions (n=6 each).
doi:10.1371/journal.pone.0004157.g006
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mCrePR allele was identified by PCR using primers 59-TATA-
GGTACCCAGAAGTGAATTCGGTTCGC-39,5 9-GGCGAC-
GTTGTTAGTACCTGAC-39 and 59-GTGCAGCATGTTCA-
GCTGGC-39.
Eno2-STOP-DTA mouse [26] was backcrossed 7 times to the
C57BL/6 strain. The Eno2-STOP-DTA allele was identified by PCR
using primers 59-AATTCTTAATTAAGGCGCGCGGG-39,5 9-
GTCAGAATTGAGGAAGAGCTGGGG-39 and 59-CACTGAG-
GATTCTTCTGTGG-39. Breeding and maintenance of mice were
carried out under institutional guidelines. Mice were fed ad libitum
with standard laboratory chow and water in standard animal cages
under a 12 h light/dark cycle. All animal procedures were approved
by the Animal Care and the Use Committee of Graduate School of
Medicine, the University of Tokyo (Approval #1721T062).
Induction of CrePR recombinase activity
RU-486 (Sigma, St. Louis, MO) was suspended at a
concentration of 50 mg/ml in water containing 0.25% carbox-
ymethyl cellulose (Sigma) and 0.5% Tween 80 (Sigma). We
injected 1 mg per g body weight of RU-486 into the peritoneum of
mice at P42.
Histochemistry
Under deep pentobarbital anesthesia (100 mg/kg), animals were
perfused transcardially with 4% paraformaldehyde in 0.1 M phos-
phate buffered salts (PBS). b-Galactosidase staining was conducted as
described previously [25]. Immunohistochemistry was performed as
described previously [27] using antibodies against neuronal nuclei
(NeuN), enkephalin, glutamic acid decarboxylase (GAD), substance P
(Chemicon International, Temecula, CA), tyrosine hydroxyrase
(Santacruz Biotechnology, Santa Cruz, CA), and calbindin. The
numbers of NeuN-positive cells per 8.7610
22 mm
2 were counted at
the dorsolateral part of CP,dorsomedial part of NAc core, the medial
part of the NAc shell (AP=1.2 mm from bregma), and the LA
(AP=21.7 mm) in the coronal brain sections. Only unequivocally
stained cellswere counted using the ImageJ software by two observers
blind to the origin of the sections.
Terminal deoxynucleotidyl transferase-mediated dUTP nick-
end labeling (TUNEL) histochemistry was performed using
ApopTag Fluorescein Direct In Situ Apoptosis Detection Kit
(Chemicon International) according to the instructions of the
manufacturer. In brief, sections were incubated in PBS containing
20 mg/ml proteinase K (Ambion, Austin, TX) at room temper-
ature for 15 min, washed and stained using FITC-labeled dUTP
and terminal deoxynucleotide transferase (TdT) (Chemicon
International) at 37uC for 60 min. After TUNEL reaction was
terminated, slides were mounted using Vectashield H-1500
mounting solution that contains DAPI (Vector, Burlingame,
CA). Confocal images were obtained using confocal microscopes
(TCS-SP5, Leica, Wetzlar, Germany).
Fear conditioning
A computer-controlled fear conditioning system (CL-M2;
O’Hara, Tokyo, Japan) was used in the fear conditioning
Figure7.Impairmentoflong-term fearmemory. A, Experimental design. Micewere injected withRU-486or vehicle. Fourteendays after treatment,
the animals were subjected to auditory fear conditioning with a weak footshock at 0.3 mA. Freezing responses to tone were measured 1 or 3 h and 24 h
after conditioning. B, Freezing responses of control (open circles, n=8) and mutant (filled circles, n=5) mice 1 h (left) and 24 h (right) after conditioning.
C, Freezing responses of control (open circles, n=6) and mutant (filled circles, n=4) 3 h (left) and 24 h (right) after conditioning. D, Experimental design.
Mice were subjected to auditory fear conditioning with a footshock at 0.3 mA or 0.5 mA. One day after conditioning, the conditioned mice were injected
with RU-486 orvehicle. Their freezing responses were measured 14days after drug treatment. E, Micewere subjected to auditory fear conditioningwith a
weak footshock at 0.3 mA. Freezing responses of mock-injected (open circles, n=7) and RU-486-injected (filled circles, n=8) mice on the conditioning
(left) and test (right) days. F, Mice were subjected to auditory fear conditioning with the standard footshock at 0.5 mA. Freezing responses of mock-
injected (open circles, n=6) and RU-486-injected (filled circles, n=7) mice on the conditioning (left) and test (right) days.
doi:10.1371/journal.pone.0004157.g007
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polyvinyl chloride boards and a stainless steel rod floor that was
composed of 14 stainless steel rods (2 mm in diameter spaced
7 mm apart) was surrounded by a sound-attenuating white chest
(74 lux). Masking noise of 52 dB was provided by a ventilation fan.
Mice were housed individually for 1 week before behavioral testing
and were handled for 30 s everyday. On the conditioning day,
mice were placed in the conditioning chamber for 2 min and then
presented with a loud tone (65 dB, 10 kHz) for 1 min through a
speaker on the ceiling of the conditioning chest. At the end of the
tone presentation, the mice were given a scrambled electrical
footshock (0.3 mA or 0.5 mA for 1 s). One minute after footshock,
the mice were returned to their home cages. The conditioning
chamber was cleaned with 70% ethanol between sessions. On the
test day, mice were placed in a novel translucent acryl chamber
with paper chips surrounded by a sound-attenuating black chest
for 6 min and subsequently for 3 min in the presence of the tone.
The test chamber was cleaned with benzalkonium (Ecolab, St.
Paul, MN) between tests. All behaviors were monitored by a CCD
camera (WAT-902B; Watec, Yamagata, Japan) attached to the
ceiling of the chest. Eight bit grayscale images (90690 pixels) were
captured at a rate of two frames per second and freezing behavior
was automatically analyzed as an index of fear using IMAGE FZC
software (O’Hara). Freezing behavior was defined as the absence
of any visible movement of the body and vibrissae except for
movement necessitated by respiration. Freezing time was sum-
mated and the percentage of freezing was calculated per minute.
To examine pain sensitivity, we measured current thresholds for
reactions of mice to nociceptive shock, namely, flinch and jump
[53]. Mice were given footshocks of increasing strength ranging
from 0.05 to 0.5 mA in a stepwise manner by 0.05 mA with an
interval of 30 s.
Motor behaviors
The stationary horizontal thin rod test was done as described
[33]. The rod was 15 mm in diameter and 50 cm long and placed
40 cm high to discourage jumping. A mouse was placed on the
midpoint of the rod, and the time it remained on the rod was
measured; animals staying for 60 sec were taken from the rod and
recorded as 60 s. Six consecutive trials were performed with an
intertrial interval of 1 h.
The accelerating rotarod test was performed with an apparatus
consisted of a 3.2 cm-diameter rod (RRAC-3002; O’Hara & Co.,
Tokyo, Japan) essentially as described [34]. During the training
period, mice were placed on the rotating rod starting at 5 rpm and
gradually accelerated to 50 rpm at a rate 0.15 rpm/s. The latency
to fall (retention time) was measured with cutoff time of 5 min.
Mice were trained for 3 consecutive days, receiving 4 trials per day
with an intertrial interval of 1 h.
In the tail suspension test [54], mice were observed for 15 s.
Abnormal movement was defined as any dystonic movement of
the hindlimbs, forelimbs, or trunk with full clasping where limbs
were pulled into the central body axis.
In the open field test, locomotor activity was measured for
9 min in a square chamber (50650640 cm) with a CCD camera
on the ceiling (OF4, O’Hara). Images were captured at a rate of
one frame per second and walking distance was automatically
measured by IMAGE OF4 software (O’Hara).
Statistics
Data are expressed as mean6SEM. The statistics significance
was evaluated using one-way or repeated measures ANOVA.
When the interaction was significant, Fisher’s PLSD post hoc test
was employed. The criterion for statistical significance was
P,0.05.
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